Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: March 29, 2023
Reporting Period: The filing incorporates by reference a press release detailing full-year financial results for the twelve months ended December 31, 2022, and recent corporate developments.
Key Financial Metrics
The provided text serves as a cover document incorporating a press release by reference. It does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for these metrics; they are contained within the attached Exhibit 99.1 (the press release) which is not included in the input text.
Material Changes
The filing highlights "Recent Corporate Developments" and "Milestone Achievements" expected to drive revenue growth in 2023. Specific details regarding material changes versus the prior comparable period are not present in the cover text.
Guidance, Outlook, and Risks
- Outlook: Management expects milestone achievements to drive revenue growth in 2023.
- Balance Sheet: The press release includes a section titled "Strengthened Balance Sheet," though specific figures are not in this text.
- Forward-Looking Statements: The filing explicitly incorporates a section on forward-looking statements from the press release.
- Conference Call: Information regarding a conference call is incorporated by reference.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release) for specific 2022 revenue, net loss, and cash position figures.
- Verify the specific "milestone achievements" cited as drivers for 2023 revenue growth.
- Confirm the details of the "Strengthened Balance Sheet" mentioned in the press release.
- Check the forward-looking statements section for specific risks and contingencies associated with the 2023 outlook.